Iwasaki et al. investigated the correlation between epigenetic inactivation of TRβ1 through aberrant methylation and clinicopathological parameters or mutations of KRAS and EGFR in 116 NSCLC surgical specimens. This evidence concerns the gene EGFR and non-small cell lung carcinoma.